Menas Elagamy

• Led strategic planning and execution for Movelex brand, achieved 120% of sales target and 89%
year-on-year growth through an optimized Go-To-Market (GTM) strategy (2024-2025)
• Used IQVIA insights to improve product performance and market share across UAE & KSA
• Executed omnichannel strategies to enhance HCP engagement and increase prescriptions
• Managed 2 Assistant Product Managers and worked with cross-functional teams across UAE, KSA,
and Jordan
• Drove digital transformation with the Egyptian Orthopedic Association, engaged 3, 000+ HCPs
through digitalized platform.
• Launched a medical podcast series featuring 25 specialist doctors, boosting HCP awareness and
engagement on disease causes, symptoms, and treatment options

• Grew Nexicure to market leader position in Esomeprazole segment; Gained 1% of total PPI market
share, contributing to top-4 ranking in IMS/IQVIA data
• Planned and executed a large-scale scientific event engaging 500+ HCPs, strengthening KOL
relationships and boosting PPI segment sales by 25% in the following quarter.
• Executed the DIVE CME program, a nationwide integrated ultrasound and endoscopy workshop
driving a 35% sales increase (S2 vs. S1).
• Partnered with IQVIA on a PST (pharmacy segmentation & targeting) program across 53K
pharmacies, identifying missed sales opportunities and strengthening brand positioning in high
volume outlets.
• Contributed to the Nexicure medical content page, ensuring full compliance with EDA (Egyptian
Drug Authority) regulations.
• Supported pipeline research for product acquisition and registration

-Nutrition
• Managed Swiss clinical nutrition portfolio (Medidrink: Onco, Pulmo, Plus) as the first disease
specific oral nutrition, following a patient-centric approach
• Managed 1 Assistant Product Manager
• Drove Sulbacef to anti-infective market leadership with 55% unit growth (2020-2021)
• Repositioned Sulbacef within COVID-19 treatment protocols across quarantine hospitals,
achieving 110% of sales target.
• Managed orthopedic and anti-infective portfolio, including 2 antibiotics (oral and injectable)
• Collaborated with sales and medical teams to improve product adoption.

• Managing portfolio of Switzerland products of clinical nutrition Medidrink (Onco- Pulmo
Plus) as the first disease specific oral clinical nutrition.
• Supervision on assistant product manager
• Developed and executed annual marketing plans
• Conducted market and product analysis
• Led branding and promotional strategy
• Managing orthopedic and Anti-infective portfolio with 2 antibiotics (oral and injectable)
• Market analysis and KOL access

• Led the launch of the first ODF oral dissolvable films in Egypt and MENA region including
Nerhasilda for OTC erectile dysfunction market, driving portfolio expansion and market
differentiation.
• Developed go-to-market strategy and campaign plans for product launch
• Conducted market analysis to support ODF technology launch
• Expanded OTC business in the erectile dysfunction segment, growing market presence through
targeted ATL & BTL campaigns.

• Managed full product lifecycle (Derma & OTC) from strategic planning to execution
• Developed and executed GCC go-to-market strategy, exporting directly to UAE & KSA, and
collaborating with cross-regional teams on launches and regulatory requirements
• Supervised packaging design and selection of promotional materials
• Conducted regular customer visits to ensure needs satisfaction.

• Promoting & launching a new molecule of fluoroquinolones in the market
• Specialized with chest physicians & Otorhinologist awareness

• Promoted & launched a new molecule of fluoroquinolones in the market
• Built strong relationships with physicians (chest and ENT) specialist for effective sales growth.